SEC Form 4 · accession 0001628280-26-058670
OptimizeRx Corp · OPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brendan W. Merrell
Officer — CHIEF OPERATING OFFICER
Period of report
Aug 20, 2026
Accepted (ET)
Aug 24, 2026 · 4:57 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001448431
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 20, 2026 | A | 57,600 | $0.00 | A | 82,787 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 20, 2027, which is the first anniversary of the grant date.
Remarks
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.